Avita Medical (ASX:AVH)
ASX announcement history & article coverage
Transparent by design.
Announcments by Avita Medical (ASX:AVH) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - AVH
Notification regarding unquoted securities - AVH
Notification of cessation of securities - AVH
Notification of cessation of securities - AVH
AVITA Highlights first UK Clinical Experience with RECELL GO
Financial Report on Form 8-K Dated 5 June 2026
Change of Director's Interest Notice -SC JCC RM JSR MT CV JW
Notification regarding unquoted securities - AVH
Notification regarding unquoted securities - AVH
Statement of CDIs on issue - AVH
2026 ASM Board Chair Script
Change of Director's Interest Notice - JW
Results of 2026 Annual Meeting of Stockholders
Change of Director's Interest Notice
Notification regarding unquoted securities - AVH
Notification of cessation of securities - AVH
AVITA AU Q1 Investor Briefing Presentation
AVITA Medical to Host Investor Webinar Briefing
Financial Results for Quarter Ending 31 March 2026
AVITA Medical reports Q1 2026 net loss of $10.6M, secures $60M credit facility, signs $25.5M BARDA deal, appoints new CEO
AVITA Medical Q1 2026 Earnings Presentation
AVITA Medical Q1 2026 revenue rises 4%, secures BARDA deal, Cohealyx shows faster grafting
AVITA Medical Reports First Quarter 2026 Financial Results
AVITA Medical Q1 2026 revenue rises 4%, net loss narrows; new CEO appointed and BARDA deal secured
Statement of CDIs on issue - AVH
Notification of cessation of securities - AVH
Company Administration - Other
AVITA Medical Names Cary Vance as Chief Executive Officer
AVITA Medical Names Cary Vance CEO and Jan Stern Reed Board Chair
AVITA Secures Australia & NZ Clearance for RECELL GO
AVITA Medical's RECELL GO Gains Regulatory Approval in Australia and New Zealand
AVITA to Announce First Quarter 2026 Financial Results
AVITA Medical to Report Q1 2026 Financial Results on May 14
Notice of Annual General Meeting/Proxy Form
AVITA KOL Investor Webinar Presentation on Cohealyx
AVITA Founder Fiona Wood recognized by ABA
AVITA Announces Positive Interim Results from Cohealyx study
AVITA Medical Reports Positive Interim Cohealyx Study Results with Nearly 20-Day Reduction in Time to Skin Grafting
